NM

Nitesh Mishra

Active Director Director DIN 02899635
DIN 02899635 First appointment Feb 2010 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2010
Shareholding value •••• Premium profile

About Nitesh Mishra

Data last updated:

Nitesh Mishra is a Director at Olampus Pharmaceuticals Private Limited (since 2010). The company operates in Healthcare. Olampus Pharmaceuticals Private Limited reported revenue of ₹49.4 Lakh (FY 2024).

DIN 02899635
Primary Designation Director
Industry Healthcare
First Appointment 10 Feb 2010
Oldest Company Age 16 yrs
Largest company Olampus Pharmaceuticals Private Limited · ₹49.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Feb 20102010₹49.4 Lakh (FY 2024)Active

Board colleagues of Nitesh Mishra

Directorship timeline

Open interactive timeline →
Olampus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nitesh Mishra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitesh Mishra

Nitesh Mishra currently holds 1 directorship: Olampus Pharmaceuticals Private Limited (Director, since 10 Feb 2010, revenue ₹49.4 Lakh (FY 2024)).

Nitesh Mishra was first appointed on 10 Feb 2010 as Director at Olampus Pharmaceuticals Private Limited.

The current boards of Nitesh Mishra's companies include Amrita Mishra (Olampus Pharmaceuticals Private Limited), Rajeev Ranjan (Olampus Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available